Please use this identifier to cite or link to this item:
http://hdl.handle.net/11434/2143
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ponsford, Jennie | - |
dc.contributor.author | Spitz, Gershon | - |
dc.contributor.author | Roberts, Caroline | - |
dc.contributor.other | Hicks, Amelia | - |
dc.contributor.other | Dore, Vincent | - |
dc.contributor.other | Krishnadas, Natasha | - |
dc.contributor.other | Rowe, Christopher | - |
dc.date.accessioned | 2022-10-04T02:21:02Z | - |
dc.date.available | 2022-10-04T02:21:02Z | - |
dc.date.issued | 2022-10 | - |
dc.identifier.uri | http://hdl.handle.net/11434/2143 | - |
dc.description.abstract | Aims: 1.to assess amyloid-β and tau burden in long-term TBI survivors and healthy controls using PET imaging. 2. to examine PET data in relation to time since injury and age at injury. TBI has been increasingly promoted as a risk factor for Alzheimer’s disease. Evidence of amyloid-β and tau beyond the initial years post injury is inconclusive. There is conflicting evidence from PET, CSF and post-mortem studies of elevated amyloid-β and tau pathology in chronic TBI survivors compared to controls. The relationships between amyloid-β and tau pathology and injury characteristics, such as time since injury and age at injury, are also unclear. | en_US |
dc.subject | Amyloid-β and Tau | en_US |
dc.subject | Traumatic Brain Injury | en_US |
dc.subject | TBI | en_US |
dc.subject | PET Imaging | en_US |
dc.subject | Alzheimer’s Disease | en_US |
dc.subject | Monash Epworth Rehabilitation Research Centre, Epworth Healthcare, Richmond, Victoria, Australia | en_US |
dc.subject | Rehabilitation, Mental Health and Chronic Pain Clinical Institute, Epworth HealthCare, Victoria, Australia. | en_US |
dc.title | Amyloid-β and tau imaging in chronic traumatic brain injury: a cross-sectional study. | en_US |
dc.type | Conference Poster | en_US |
dc.description.affiliates | Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Australia. | en_US |
dc.description.affiliates | Department of Molecular Imaging and Therapy, Austin Health, Australia | en_US |
dc.description.affiliates | Florey Department of Neuroscience and Mental Health, University of Melbourne, Australia | en_US |
dc.description.affiliates | CSIRO Health and Biosecurity Flagship, The Australian e-Health Research Centre, Australia | en_US |
dc.type.studyortrial | Cross-Sectional Study | en_US |
dc.description.conferencename | Epworth HealthCare Research Month 2022 | en_US |
dc.description.conferencelocation | Epworth Research Institute, Victoria, Australia | en_US |
dc.type.contenttype | Text | en_US |
Appears in Collections: | Research Week |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Hicks A Amyloid-beta and Tau Imaging.pdf | 1.31 MB | Adobe PDF | View/Open |
Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.